Samuel A Wells
Affiliation: Washington University School of Medicine
- Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancerSamuel A Wells
Dept of Surgery, Washington University School of Medicine, Box 8109, 660 S Euclid Ave, St Louis, MO 63110, USA
J Clin Oncol 28:767-72. 2010..These results demonstrate that vandetanib may provide an effective therapeutic option in patients with advanced hereditary MTC, a rare disease for which there has been no effective therapy...
- Hereditary medullary thyroid carcinoma in patients greater than 50 years oldFrank J Quayle
Department of Surgery, Washington University School of Medicine, 660 S Euclid, St Louis, MO 63139, USA
Surgery 136:1116-21. 2004..Despite near complete penetrance and frequent early evaluation of medullary thyroid carcinoma (MTC) in multiple endocrine neoplasia 2 (MEN 2) variants, a significant minority of patients are evaluated later in life...
- Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective analysisMark S Cohen
Department of Surgery, Washington University School of Medicine, St Louis, MO, USA
Surgery 138:1033-40; discussion 1040-1. 2005..The functional results of cryopreserved heterotopic parathyroid autotransplantation (CHPA) are not well defined. The authors evaluated the outcomes of delayed CHPA for the treatment of surgically induced hypoparathyroidism...